EC Number | Activating Compound | Comment | Organism | Structure |
---|---|---|---|---|
4.1.1.22 | toluene 2,4-diisocyanate | toluene 2,4-diisocyanate provocation causes acute allergy-like behaviors along with significant up-regulation of HDC mRNA expression and increased HDC activity | Rattus norvegicus |
EC Number | Application | Comment | Organism |
---|---|---|---|
4.1.1.22 | medicine | suppression of histamine signaling by inhibition of HDC may be a novel target of probiotics in preventing allergic diseases | Rattus norvegicus |
EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
4.1.1.22 | additional information | Lac-B (a mixture of freeze-dried Bifidobacterium infantis and Bifidobacterium longum) shows significant anti-allergic effect through suppression of both H1R and HDC gene expression followed by decrease in H1R, HDC protein level, and histamine content, oral administration of the Lac-B suspension significantly suppresses the toluene 2,4-diisocyanate-induced HDC mRNA up-regulation | Rattus norvegicus |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
4.1.1.22 | Rattus norvegicus | - |
- |
- |
EC Number | Source Tissue | Comment | Organism | Textmining |
---|---|---|---|---|
4.1.1.22 | nasal mucosa | - |
Rattus norvegicus | - |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
4.1.1.22 | L-histidine | - |
Rattus norvegicus | histamine + CO2 | - |
? |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
4.1.1.22 | HDC | - |
Rattus norvegicus |
EC Number | Cofactor | Comment | Organism | Structure |
---|---|---|---|---|
4.1.1.22 | pyridoxal 5'-phosphate | - |
Rattus norvegicus |